NASHUA, N.H., July 22, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter and six-months ended June 30, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Thursday, August 5.
| Thursday, August 5th @ 4:30pm ET | |
| Domestic: | 888-254-3590 |
| International: | 323-994-2082 |
| Conference ID: | 6177004 |
| Webcast: | http://public.viavid.com/index.php?id=145901 |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com
VANCOUVER, BC, March 28, 2025 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF)…
The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia Measuring…
SCOTTSDALE, Ariz., March 28, 2025 /PRNewswire/ -- SimonMed Imaging confirmed that it experienced a data incident…
Kindred Capital backs Sohar Health's mission to remove one of care's biggest hidden barriers and…
Willow acquires Elvie to develop a global multi-category platform offering a diverse range of maternal…
Award honors groundbreaking innovations in extended reality across reality platforms, spanning hardware, software and content…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="1px" width="1px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
